“We have an average of about 1.4 million new cancer patients being...
Category:
Eco/Invest/Demography
Latest
24% deaths recorded in Delhi occurred due to infectious, parasitic diseases: Report
The number of institutional deaths due to cancer and related...
China unveils $1.4 trillion local debt package but no direct stimulus
In an apparent reaction to the U.S. election and the intensifying...
Genetic study of liver cancer reveals new drug target
The conclusion of the new study analyzing the genetics of HCC tumours was published in the journal PLOS Genetics by Augusto Villanueva of the Icahn School of Medicine at Mount Sinai and colleagues.”The study uncovered the role of cancer-testis antigens, specifically MAGEA3, in liver cancer progression,” Villanueva adds.
Govt extends I-T compliance deadlines; exempts tax on COVID treatment cost, ex-gratia payments from employers
“In order to ensure that no income tax liability arises on this account, it has been decided to provide income-tax exemption to the amount received by a taxpayer for medical treatment from employer or from any person for treatment of Covid-19 during FY 2019-20 and subsequent years,” it added.
U.S. approves Roche drug for emergency use against severe COVID-19
The drug can be used to treat patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation, the FDA said, adding studies showed Actemra helped reduce the risk of death and speed recovery.
For months already, the medicine has been given to severely ill COVID-19 patients on a compassionate-use basis, generating hundreds of millions in sales for Roche.
Pfizer halts distribution of anti-smoking drug after finding carcinogen
The drugmaker is recalling a number of lots of anti-smoking drugs. The U.S. drug regulator has in the past reached out to companies whose drugs had N-nitrosodimethylamine (NDMA) over accepted levels.
The Food and Drug Administration (FDA) last year found high levels of NDMA in some versions of the popular diabetes drug metformin. NDMA contamination was responsible for the recall of the heartburn drug Zantac sold by Sanofi SA in 2019.
Third wave of coronavirus unlikely to be as severe as second wave: ICMR Study
Presenting a vaccine ramp-up scenario where 40 percent of the population has received two doses within three months of the second wave peak, and further that the effect of vaccination is (conservatively) to reduce severity of infection by 60 percent, the study said it illustrates how vaccination could substantially reduce the overall burden during the possible third wave.
Expert panel formed to tackle possible third Coronavirus wave in children
“Children may be asymptomatic and remain super- spreaders. No studies have supported infection spreading via lactation and hence a feeding mother can proceed with feeding, but always wear a mask and give the baby to be looked after by others after feeding,” the document further states.
776 doctors died in Covid second wave, says Indian Medical Association
According to the IMA COVID registry – state-wise Doctors martyrs list, Bihar saw the maximum number of 115 deaths, followed by Delhi at 109, Uttar Pradesh 79, West Bengal 62, Rajasthan 44, Jharkhand 39, and Andhra Pradesh 40.According to the IMA, 748 doctors died in the first wave of the pandemic.
India logs 51,667 new COVID-19 cases, 1,329 deaths in last 24 hours
RBI prescribes qualifications for MDs, WTDs of urban cooperative banks
it has been decided that all UCBs having asset size of Rs 5,000 crore or above, shall appoint a Chief Risk Officer (CRO). The Board must clearly define the CRO’s role and responsibilities and ensure that he/she functions independently,” the circular said. The CRO should have direct reporting lines to MD/CEO or Board or the Risk Management Committee of the Board (RMC), it added.
Virus that causes Covid-19 can find alternate route to infect cells: Study
Now, researchers at Washington University School of Medicine in St. Louis have found that a single mutation gives SARS-CoV-2 the ability to enter cells through another route – one that does not require ACE2. The ability to use an alternative entry pathway opens up the possibility of evading COVID-19 antibodies or vaccines, but the researchers did not find evidence of such evasion. However, the discovery does show that the virus can change in unexpected ways and find new ways to cause infection. The study is published in the journal Cell Reports.